Pre-publication drafts are reproduced with permission and copyright © 2013 of the Journal of Orthopaedic Trauma [Mutch J, Rouleau DM, Laflamme GY, Hagemeister N. Accurate Measurement of Greater Tuberosity Displacement without Computed Tomography: Validation of a method on Plain Radiography to guide Surgical Treatment. J Orthop Trauma. 2013 Nov 21: Epub ahead of print.] and copyright © 2014 of the British Editorial Society of Bone and Joint Surgery [Mutch JAJ, Laflamme GY, Hagemeister N, Cikes A, Rouleau DM. A new morphologic classification for greater tuberosity fractures of the proximal humerus: validation and clinical Implications. Bone Joint J 2014;96-B:In press.] / Les fractures isolées de la Grosse Tubérosité (GT) de l’humerus proximal sont rares et peu étudiées. Trois problèmes importants existent: 1: Même si 5mm + de déplacement supérieur du GT est cité comme indication chirurgicale, les mesures basées sur radiographie peuvent errer de plus que 10mm. 2: Les classifications de Neer et l’AO décrivent seulement un type de fracture de GT (gros fragment, ligne de fracture verticale). Deux autres types de fracture existent: type fracture-avulsion avec petit fragment osseux et type Hill-Sachs très latéral. 3: On manque d’études de pronostic ou de traitement des fractures de GT selon la morphologie. Article 1 montre et évalue une méthode simple de mesurer le déplacement supérieur de la GT (le GT ratio) sur les radiographies standard; ceci corrèle très bien avec tomographie (CT). Article 2 introduit une méthode de classification Morphologique des fractures de GT (Avulsion, Split, Dépression) qui a une fiabilité de bonne à excellente. Les données échographiques, radiologiques, et cliniques de 54 patients porteurs de fracture de GT (suivie moyenne 2.5 années) sont aussi incluses. Les patients <50 ans ont eu plus de déchirures de la coiffe et ceux avec fractures déplacées (≥ 5mm) avaient plus d’atrophie du susépineux. Les déchirures complètes de la coiffe et l’atrophie du susépineux augmentaient l’atteinte permanente. La morphologie des fractures de GT n’a pas eu un impact significatif sur le pronostic. Cependant, l’âge, le sexe, et le taux de luxation glénohumérale étaient différents selon le type de fracture et ceci pourrait refléter la pathophysiologie. Une évaluation plus précise de l’impact de la Morphologie des fractures de GT sur le pronostic et traitement nécessitera une étude prospective multicentrique. / Isolated fractures of the Greater Tuberosity (GT) of the proximal humerus are rare and a challenge to study. Three main problems arise: 1: Though 5mm+ superior GT displacement is often a surgical indication, measurement errors on radiographs may surpass 10mm. 2: The Neer and AO classifications describe only one type of GT fracture (large fragment, vertical fracture line). Two other fracture types have been described: an avulsion-type (small fragment), and a very lateral Hill-Sachs-type. 3: There are no studies on the treatment or prognosis of GT fractures according to fracture morphology. Article 1 introduces and tests a simple method to measure superior GT displacement (the GT ratio) using standard radiographs; this correlates very well with computed tomography (CT). Article 2 presents the Morphologic classification for GT fractures. It describes three fracture types (Avulsion, Split, Depression) and has good to excellent reliability. The ultrasonographic, radiologic, and clinical results of 54 patients (average follow-up 2.5 years) with isolated GT fractures are then described. Patients <50 years had higher rates of rotator cuff tears and displaced (≥ 5mm) GT fractures were associated with supraspinatus atrophy. Both full rotator cuff tears and supraspinatus atrophy resulted in poor outcomes. The impact of fracture morphology on prognosis was not significant. However, age, sex, and associated glenohumeral dislocation differed by fracture type and this may reflect their pathophysiology. A more thorough evaluation of the prognosis and treatment of GT fractures by morphologic type would require a prospective multicenter study.

INTRODUÇÃO: Emulsão lipídica parenteral composta por óleo de peixe, rica em ácidos graxos ômega-3, é infundida associada a emulsões lipídicas convencionais, como parte da terapia nutricional parenteral. Em pacientes cirúrgicos, a infusão perioperatória de emulsão lipídica de óleo de peixe se associa à preservação de funções imunológicas e modulação favorável de mediadores inflamatórios pós-operatórios, com redução na frequência de complicações infecciosas e no tempo de internação em unidade de terapia intensiva e hospitalar. Os benefícios descritos encorajam a infusão parenteral isolada de emulsão lipídica de óleo de peixe, como fármaconutriente adjuvante no tratamento de pacientes cirúrgicos, independente da indicação de terapia nutricional parenteral. OBJETIVO: O presente estudo avaliou o efeito da infusão parenteral pré-operatória, por curto prazo, de emulsão lipídica de óleo de peixe isolada sobre a resposta imunológica pósoperatória e a evolução clínica imediata de pacientes com câncer gastrintestinal. MÉTODOS: Estudo prospectivo, aleatório, duplo-cego e controlado em 63 pacientes cirúrgicos eletivos com câncer gastrintestinal. Os doentes receberam infusão por veia periférica (0,2g gordura/kg de peso corpóreo/dia) de emulsão lipídica parenteral de óleo de peixe (Omegaven® 10% - Fresenius-Kabi) ou emulsão lipídica parenteral controle (Lipovenos MCT® 10% - Fresenius-Kabi) durante os 3 últimos dias pré-operatórios. Amostras de sangue foram coletadas antes e após a infusão parenteral das emulsões lipídicas e nos 3º e 6º (apenas para citocinas) dias pósoperatórios. Analisou-se a concentração plasmática de IL-6 e IL-10 e a migração, fagocitose, explosão oxidativa e expressão de moléculas HLA-DR e CD32 leucocitárias. A frequência de complicações infecciosas e tempo de internação na unidade de terapia intensiva e hospitalar também foram avaliados no período pós-operatório imediato. RESULTADOS: No período pós-operatório, pacientes tratados com emulsão de óleo de peixe tiveram aumento de IL-10 (dia 3, p < 0,0001), diminuição de IL-6 (dia 3, p = 0,029) e IL-10 (dia 6 p < 0,0001), menor diminuição da explosão oxidativa leucocitária (p = 0,028), manutenção da porcentagem de monócitos exprimindo HLA-DR (p = 0,046) e CD32 (p = 0,025) e aumento da intensidade da expressão de CD32 por neutrófilos (p=0,010), em comparação a pacientes tratados com emulsão lipídica controle. A migração leucocitária não foi influenciada. Não foram encontradas diferenças na frequência de infecções e no tempo de permanência na unidade de terapia intensiva e hospitalar. CONCLUSÕES: A infusão pré-operatória, por curto prazo, de emulsão lipídica parenteral de óleo de peixe isolada, como fármaco-nutriente, melhora a resposta imunológica pós-operatória de pacientes com câncer gastrintestinal sem estar associada à melhora significativa na frequência de infecções e tempo de permanência na unidade de terapia intensiva e hospitalar. / BACKGROUND: Parenteral lipid emulsion composed by fish oil, rich in omega-3 fatty acids, is infused in addition to other standard lipid emulsions, as part of parenteral nutrition therapy. In surgical patients, the perioperative infusion of fish oil lipid emulsion is associated with immune functions preservation and favorably modulation of postoperative inflammatory mediators, with decreased infectious complications and length of intensive care unit and hospital stay. These reported benefits encourage the use of fish oil lipid emulsion alone, as a pharmacological adjuvant agent for the treatment of surgical patients, independent of parenteral nutritional therapy indication. AIM: This clinical trial assessed the effect of short-term preoperative infusion of fish oil lipid emulsion alone on postoperative immune response and immediate clinical outcomes of patients with gastroenterological cancer. METHOD: In a prospective, randomized, controlled and double-blind design, elective surgical patients with gastrointestinal cancer (n= 63) received, for the last 3 pre-operative days, peripheral infusion (0.2g fat/kg of body weight./d) of fish oil lipid emulsion (Omegaven® 10% - Fresenius-Kabi) or control lipid emulsion (Lipovenos MCT® 10% - Fresenius-Kabi). Peripheral blood samples were collected before and after lipid emulsion infusion at the 3rd and 6th (only for cytokines) postoperative days to analyze plasma concentration of IL-6 and IL-10, as well as leukocyte migration, phagocytosis, oxidative burst and expression of HLADR and CD32 molecules. Postoperative infections, length of intensive care unit and hospital stay were also measured. RESULTS: At postoperative period, patients treated with fish oil lipid emulsion had increase of IL-10 (day 3, p < 0.0001), decrease of IL-6 (day 3, p = 0.029) and IL-10 (day 6, p<0.0001), lower decrease of leukocyte oxidative burst (p=0.023), maintenance of the percentage of monocytes expressing HLA-DR (p=0.046) and CD32 (p=0,025) and increase of the intensity of CD32 expression on neutrophil surface (p=0,010), when compared to patients treated to control lipid emulsion. The leukocyte chemotaxis was not affected. No changes were observed on postoperative infections and length of intensive care unit and hospital stay. CONCLUSION: Short-term preoperative infusion of fish oil lipid parenteral emulsion alone improves postoperative immune response of patients with gastrointestinal cancer without benefit on infections frequency and length of intensive care unit and hospital stays.

In dieser Arbeit wurden Genexpressionsprofile diffuser und intestinaler Magenadenokarzinome mittels Microarray-Technik erstellt. Der intestinale Typ konnte als stark proliferierender Tumor mit signifikanter Überexpression von zellzyklusrelevanten Genen definiert werden, während der diffuse Typ als stark stromaabhängig mit signifikanter Überexpression von Genen der extrazellulären Matrix hervortrat. Thrombospondin 4 (THBS4) wurde dabei als das am stärksten differentiell exprimierte Gen identifiziert, wobei seine mRNA in diffusen Tumoren eminent überexprimiert wird. Immunhistochemische Studien bestätigten diese starke Überexpression auf Proteinebene und zeigten, dass THBS4 eine übermäßig angereicherte extrazelluläre Komponente des Tumorstromas ist. Kolokalisierungsstudien zeigten zudem, dass THBS4-positive Zellen auch positiv für Vimentin und Smooth muscle actin (alpha) sind. Diese Ergebnisse belegen, dass THBS4 von Tumor-assoziierten Fibroblasten (TAF) exprimiert wird. Dies konnte durch zusätzliche in vitro Experimente bestätigt werden, die aufzeigten, dass TAF von diffusen Tumoren eine stärkere THBS4-mRNA Expression aufweisen als normale Fibroblasten des Magens. Abschließend konnten in vitro Kokultur-Studien aufdecken, dass die THBS4-Expression in Fibroblasten durch Tumorzellen diffuser Magentumore transkriptionell stimuliert wird. Metastasenbefall regionaler Lymphknoten (N+) ist bei den meisten Magenadenokarzinomdiagnosen bereits vorhanden. Dieser ist der stärkste derzeit verfügbare Parameter zur Abschätzung der Prognose, reicht aber für eine eindeutige Vorhersage nicht aus. Um ergänzende molekulare Prognoseindikatoren zu identifizieren, wurden aus den Microarray-Daten Gene, deren Expression mit dem klinischen Verlauf von N+ Patienten korreliert, extrahiert. Einige dieser Gene, z.B. RAN binding protein 17 und ras-related associated with diabetes, konnten mittels quantitativer real-time PCR als Marker für verkürztes progressionsfreies Überleben validiert werden. / In this work, gene expression profiles of diffuse and intestinal-type gastric adenocarcinomas were established using the microarray technique. The intestinal type was identified to be a highly proliferative entity with significant overexpression of cell cycle-relevant genes, whereas the diffuse type was proven to be strongly stroma-dependent with significant overexpression of extracellular matrix genes. Thrombospondin 4 (THBS4) was identified as the gene most differentially expressed between the two types with vast mRNA overexpression in diffuse-type tumors. Immunohistochemical studies proved overexpression on protein level and elucidated that THBS4 is a heavily accumulated extracellular constituent of the tumor stroma. Colocalization studies uncovered that THBS4-positive cells are also positive for vimentin and alpha-smooth muscle actin. These data signify that THBS4 is expressed by subpopulations of cancer-associated fibroblasts (CAFs). This was further evidenced by in vitro experiments demonstrating that THBS4 mRNA expression is increased in CAFs of diffuse-type tumors compared to normal gastric fibroblasts. Finally, in vitro coculture studies revealed that transcriptional THBS4 expression in fibroblasts is stimulated by diffuse-type gastric tumor cells. Metastatic involvement of regional lymph nodes (N+) usually accompanies diagnosis of gastric adenocarcinoma and is currently considered the most important parameter for assessment of prognosis. However, estimation of prognosis based on this parameter alone is not sufficiently reliable. In order to identify additional molecular prognosis markers, genes whose expression correlates with clinical outcome of N+ patients were extracted from the microarray data. Via quantitative real-time PCR, several genes, e.g. RAN binding protein 17 and ras-related associated with diabetes, were successfully validated to allow an expression-based stratification of patients with respect to disease-free survival.

Objective: To assess in a prospective trial the influence of the amount of tissue resected at transurethral resection of the prostate (TURP) for benign prostatic enlargement on the symptom improvement as assessed by symptom scores. Methods: Between December 1996 and August 1998 a total of 138 men (mean age 68.2, range 53–89) with symptomatic benign prostatic enlargement who underwent TURP participated in this prospective study. Patients were assessed preoperatively with the International Prostate Symptom Score (IPSS), the American Urological Association Bother Score (AUA–BS) and the Benign Prostatic Hyperplasia Impact Index (BPH–II) as well as urinary flow rate measurements (Qmax) and prostate volume (PV) and residual urine determination by ultrasound. The amount of tissue resected was weighed. Patients were followed with reevaluation of Qmax, residual urine and the symptom and bother scores at 3 and 6 months. Results: A close correlation between preoperative PV (mean 49.0 ml, SD 22.0, range 13–140) and the resected tissue weight (RTW, mean 24.7 g, SD 18.0, range 6–128) was seen (r = 0.75, p<0.001). Age was correlated with preoperative PV (r = 0.23, p<0.05). While significant mean improvements in Qmax, residual volume and IPSS, AUA–BS and BPH–II were found 3 and 6 months postoperatively, a negative correlation was seen between the RTW and the IPSS, the AUA–BS and the BPH–II 3 months after TURP (r = –0.23, p<0.024; r = –0.23, p<0.025; r = –0.20, p = 0.05). No statistically significant correlation was seen between symptom change and the percentage of PV removed or the residual prostatic weight. Classification of the patients into groups depending on preoperative PV (<30, 31–50, 51–70 and >70 ml) showed a tendency for patients with larger PV to gain more symptom improvement postoperatively. Conclusions: Early symptom improvement after TURP will depend on the amount of tissue removed but the relationship is weak and affected by several other confounding factors. Apparently, the symptomatic improvement after TURP is not primarily dependent on the relative completeness of the resection. Patients with larger prostates and larger RTW tend to gain more symptomatic benefit from TURP than do patients with smaller prostates. / Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.

INTRODUÇÃO: Emulsão lipídica parenteral composta por óleo de peixe, rica em ácidos graxos ômega-3, é infundida associada a emulsões lipídicas convencionais, como parte da terapia nutricional parenteral. Em pacientes cirúrgicos, a infusão perioperatória de emulsão lipídica de óleo de peixe se associa à preservação de funções imunológicas e modulação favorável de mediadores inflamatórios pós-operatórios, com redução na frequência de complicações infecciosas e no tempo de internação em unidade de terapia intensiva e hospitalar. Os benefícios descritos encorajam a infusão parenteral isolada de emulsão lipídica de óleo de peixe, como fármaconutriente adjuvante no tratamento de pacientes cirúrgicos, independente da indicação de terapia nutricional parenteral. OBJETIVO: O presente estudo avaliou o efeito da infusão parenteral pré-operatória, por curto prazo, de emulsão lipídica de óleo de peixe isolada sobre a resposta imunológica pósoperatória e a evolução clínica imediata de pacientes com câncer gastrintestinal. MÉTODOS: Estudo prospectivo, aleatório, duplo-cego e controlado em 63 pacientes cirúrgicos eletivos com câncer gastrintestinal. Os doentes receberam infusão por veia periférica (0,2g gordura/kg de peso corpóreo/dia) de emulsão lipídica parenteral de óleo de peixe (Omegaven® 10% - Fresenius-Kabi) ou emulsão lipídica parenteral controle (Lipovenos MCT® 10% - Fresenius-Kabi) durante os 3 últimos dias pré-operatórios. Amostras de sangue foram coletadas antes e após a infusão parenteral das emulsões lipídicas e nos 3º e 6º (apenas para citocinas) dias pósoperatórios. Analisou-se a concentração plasmática de IL-6 e IL-10 e a migração, fagocitose, explosão oxidativa e expressão de moléculas HLA-DR e CD32 leucocitárias. A frequência de complicações infecciosas e tempo de internação na unidade de terapia intensiva e hospitalar também foram avaliados no período pós-operatório imediato. RESULTADOS: No período pós-operatório, pacientes tratados com emulsão de óleo de peixe tiveram aumento de IL-10 (dia 3, p < 0,0001), diminuição de IL-6 (dia 3, p = 0,029) e IL-10 (dia 6 p < 0,0001), menor diminuição da explosão oxidativa leucocitária (p = 0,028), manutenção da porcentagem de monócitos exprimindo HLA-DR (p = 0,046) e CD32 (p = 0,025) e aumento da intensidade da expressão de CD32 por neutrófilos (p=0,010), em comparação a pacientes tratados com emulsão lipídica controle. A migração leucocitária não foi influenciada. Não foram encontradas diferenças na frequência de infecções e no tempo de permanência na unidade de terapia intensiva e hospitalar. CONCLUSÕES: A infusão pré-operatória, por curto prazo, de emulsão lipídica parenteral de óleo de peixe isolada, como fármaco-nutriente, melhora a resposta imunológica pós-operatória de pacientes com câncer gastrintestinal sem estar associada à melhora significativa na frequência de infecções e tempo de permanência na unidade de terapia intensiva e hospitalar. / BACKGROUND: Parenteral lipid emulsion composed by fish oil, rich in omega-3 fatty acids, is infused in addition to other standard lipid emulsions, as part of parenteral nutrition therapy. In surgical patients, the perioperative infusion of fish oil lipid emulsion is associated with immune functions preservation and favorably modulation of postoperative inflammatory mediators, with decreased infectious complications and length of intensive care unit and hospital stay. These reported benefits encourage the use of fish oil lipid emulsion alone, as a pharmacological adjuvant agent for the treatment of surgical patients, independent of parenteral nutritional therapy indication. AIM: This clinical trial assessed the effect of short-term preoperative infusion of fish oil lipid emulsion alone on postoperative immune response and immediate clinical outcomes of patients with gastroenterological cancer. METHOD: In a prospective, randomized, controlled and double-blind design, elective surgical patients with gastrointestinal cancer (n= 63) received, for the last 3 pre-operative days, peripheral infusion (0.2g fat/kg of body weight./d) of fish oil lipid emulsion (Omegaven® 10% - Fresenius-Kabi) or control lipid emulsion (Lipovenos MCT® 10% - Fresenius-Kabi). Peripheral blood samples were collected before and after lipid emulsion infusion at the 3rd and 6th (only for cytokines) postoperative days to analyze plasma concentration of IL-6 and IL-10, as well as leukocyte migration, phagocytosis, oxidative burst and expression of HLADR and CD32 molecules. Postoperative infections, length of intensive care unit and hospital stay were also measured. RESULTS: At postoperative period, patients treated with fish oil lipid emulsion had increase of IL-10 (day 3, p < 0.0001), decrease of IL-6 (day 3, p = 0.029) and IL-10 (day 6, p<0.0001), lower decrease of leukocyte oxidative burst (p=0.023), maintenance of the percentage of monocytes expressing HLA-DR (p=0.046) and CD32 (p=0,025) and increase of the intensity of CD32 expression on neutrophil surface (p=0,010), when compared to patients treated to control lipid emulsion. The leukocyte chemotaxis was not affected. No changes were observed on postoperative infections and length of intensive care unit and hospital stay. CONCLUSION: Short-term preoperative infusion of fish oil lipid parenteral emulsion alone improves postoperative immune response of patients with gastrointestinal cancer without benefit on infections frequency and length of intensive care unit and hospital stays.

Abstract The aim was to determine the association between baseline factors, such as oral health-related behavior, attitudes, knowledge and beliefs in relation to caries increment during a randomized clinical trial (RCT). A further aim was to evaluate treatment costs and health outcomes during and after the RCT. In Pori Finland, 11- to 12-year-old children with active initial caries lesion(s) participated in the RCT in 2001–05. The experimental group (n=250) received multiple measures for controlling caries. The control group (n=247) received standard dental care. In 2005–08, all received standard dental care. Regression analyses were used to study the associations between behavioral factors and caries increment. Cost-effectiveness analysis was conducted (trial period), and costs and health outcomes as well as dental service utilization were evaluated (post-trial period). In the experimental group, brushing teeth twice a day was indicative of developing no new caries lesions, whereas eating candy at least once a day, predicted new lesions. In the experimental and control groups, lack of concern about cavities and lack of knowledge about mother’s dental health predicted new caries lesions. The average incremental cost for averting one DMF surface was €34. The experimental regimen was more effective and more costly than the standard dental care. The total costs decreased year after year. The mean total cost per adolescent was lower and the clinical outcome was better among the former participants in the experimental group. The utilization of dental services was significantly more regular among the former participants in this group. It may be feasible to control caries more effectively by affecting toothbrushing, candy eating and oral health-related attitudes, as preventive procedures may be ineffective if those factors are not in order. It is important to discuss oral health-related topics in families, because this may improve the oral health-related behavior of children. Cost-effectiveness of regimen used for the experimental group may be improved by division of work or by selective reduction of preventive procedures. Well-timed caries control can decrease treatment cost and yield long-term improvement of dental health. / Tiivistelmä Tutkimuksen tarkoituksena oli selvittää satunnaistetun kliinisen kokeen alussa rekisteröityjen suunterveyteen liittyvien tapojen, tietojen, asenteiden, uskomusten ja karieskertymän välisiä yhteyksiä. Lisäksi arvioitiin hoitokustannuksia ja hoidollisia tuloksia sekä kokeen ajalta että kokeen jälkeiseltä ajalta. Ne 11–12-vuotiaat lapset, joilla oli ainakin yksi alkava aktiivinen kariesvaurio, osallistuivat kokeeseen Porissa vuosina 2001–05. Koeryhmän lapset (n=250) saivat tehostettua ehkäisevää hoitoa ja kontrolliryhmän lapset (n=247) tavanomaista hammashoitoa. Kaikki saivat tavanomaista hammashoitoa vuosina 2005–08. Käyttäytymisellisten tekijöiden ja karieskertymän välisiä yhteyksiä tutkittiin regressioanalyysien avulla. Kustannusvaikuttavuusanalyysi tehtiin kokeen ajalta. Hoitokustannuksia ja hoidollisia tuloksia sekä palveluiden käyttöä arvioitiin kokeen jälkeiseltä ajalta. Lapsilla, jotka harjasivat vähintään kaksi kertaa päivässä, oli yleensä ehjät hampaat, kun taas lapsilla, jotka söivät päivittäin makeisia, oli useasti reikiä. Huolettomuus reikiintymistä kohtaan ja tietämättömyys äidin hampaiden kunnosta näkyi lasten hampaiden reikiintymisenä. Yhden hammaspinnan säästyminen paikkaukselta maksoi keskimäärin 34 €. Koeryhmän saama hoito oli vaikuttavampaa, mutta kalliimpaa kuin kontrolliryhmän saama hoito. Kokonaiskustannukset laskivat vuosi vuodelta. Keskimääräiset hoitokustannukset olivat pienemmät ja hammasterveys parempi entisen koeryhmän jäsenillä kuin kontrolliryhmäläisillä. Myös palveluiden käyttö oli säännöllisempää koeryhmässä. Karieksen hallintaa voidaan todennäköisesti tehostaa vaikuttamalla hampaiden harjaukseen, makeisten syöntiin ja suunterveyteen liittyviin asenteisiin. On tärkeää varmistaa, että nämä asiat ovat kunnossa, koska ehkäisevät toimenpiteet saattavat muuten jäädä tehottomiksi. Suunterveyteen liittyvistä asioista olisi hyvä keskustella perheissä, koska asioiden esillä pitäminen voi vaikuttaa suotuisasti lasten terveystapoihin. Koeryhmän saaman hoito-ohjelman kustannusvaikuttavuutta voisi todennäköisesti parantaa muuttamalla suunterveydenhuollon henkilöstön työnjakoa tai karsimalla valikoiden ehkäisevien toimenpiteiden määrää. Oikea-aikainen karieksen hallinta voi vähentää hoitokustannuksia ja lisätä hammasterveyttä pitkällä aikavälillä.

Changes in bone and mineral metabolism and the role of vitamin D in very low birth weight infants. Firstly, the aim of dissertation work was to estimate physiological parathyroid hormone (PTH) levels and their relationship with bone metabolism parameters in otherwise healthy preterm newborns with birth weight 1000-1500 g. Secondly, to evaluate vitamin D status in mothers and their very low birth weight infants (VLBW) at birth and at discharge with currently recommended supplementation of vitamin D. Thirdly, to compare clinical outcomes of VLBW infants with 25-hydroxy vitamin D [25(OH)D] levels ≤ and > 25 nmol/l in umbilical cord blood and finally to evaluate umbilical cord vitamin D as a risk factor for respiratory distress syndrome in preterm infants. It is a set of prospective observational studies involving immature newborns with birth weight below 1500 g. The parameters of mineral and bone metabolism were analysed in umbilical cord blood and newborn serum and urine during hospitalisation (PTH, 25-hydroxy vitamin D, S-Ca, S-P, ALP, U-Ca, U-P) and in pregnant women before delivery (25-hydroxy vitamin D). Bone mineralization was evaluated by bone densitometry. In a pilot study, from the total 134 examined serum samples for PTH levels the estimated reference range was 1.6 - 9.3 pmol/l. From the...

Objective: To assess in a prospective trial the influence of the amount of tissue resected at transurethral resection of the prostate (TURP) for benign prostatic enlargement on the symptom improvement as assessed by symptom scores. Methods: Between December 1996 and August 1998 a total of 138 men (mean age 68.2, range 53–89) with symptomatic benign prostatic enlargement who underwent TURP participated in this prospective study. Patients were assessed preoperatively with the International Prostate Symptom Score (IPSS), the American Urological Association Bother Score (AUA–BS) and the Benign Prostatic Hyperplasia Impact Index (BPH–II) as well as urinary flow rate measurements (Qmax) and prostate volume (PV) and residual urine determination by ultrasound. The amount of tissue resected was weighed. Patients were followed with reevaluation of Qmax, residual urine and the symptom and bother scores at 3 and 6 months. Results: A close correlation between preoperative PV (mean 49.0 ml, SD 22.0, range 13–140) and the resected tissue weight (RTW, mean 24.7 g, SD 18.0, range 6–128) was seen (r = 0.75, p<0.001). Age was correlated with preoperative PV (r = 0.23, p<0.05). While significant mean improvements in Qmax, residual volume and IPSS, AUA–BS and BPH–II were found 3 and 6 months postoperatively, a negative correlation was seen between the RTW and the IPSS, the AUA–BS and the BPH–II 3 months after TURP (r = –0.23, p<0.024; r = –0.23, p<0.025; r = –0.20, p = 0.05). No statistically significant correlation was seen between symptom change and the percentage of PV removed or the residual prostatic weight. Classification of the patients into groups depending on preoperative PV (<30, 31–50, 51–70 and >70 ml) showed a tendency for patients with larger PV to gain more symptom improvement postoperatively. Conclusions: Early symptom improvement after TURP will depend on the amount of tissue removed but the relationship is weak and affected by several other confounding factors. Apparently, the symptomatic improvement after TURP is not primarily dependent on the relative completeness of the resection. Patients with larger prostates and larger RTW tend to gain more symptomatic benefit from TURP than do patients with smaller prostates. / Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.

No description available.

L’épilepsie insulaire (ÉI) est une forme rare d’épilepsie focale qui, en raison des défis liés à son diagnostic, est difficilement cernable. De plus, la prise en charge des patients avec ÉI s’avère complexifiée par le fait que cette pathologie est fréquemment résistante aux médicaments anti-crises. Pour ces cas médico-réfractaires, la chirurgie insulaire est une option viable. Cela dit, les patients subissant une telle intervention développent fréquemment des déficits neurologiques postopératoires; heureusement, la grande majorité de ceux-ci récupèrent complètement et rapidement. Or, le mécanisme sous-tendant ce singulier rétablissement fonctionnel demeure à ce jour mal compris. Deux modalités modernes d’IRM structurelle, soit l’analyse d’épaisseur corticale et la tractographie, ont permis, dans les dernières années, de décrire les altérations architecturales caractéristiques et potentiellement diagnostiques de divers types d’épilepsie ainsi que de caractériser les remodelages plastiques qui suivent la chirurgie de l’épilepsie extra-insulaire. Cependant, à ce jour, aucune étude ne s’est encore penchée sur le cas de l’ÉI. De ce fait, les études qui constituent cette thèse exploitent l’IRM structurelle afin, d’une part, de dépeindre les altérations d’épaisseur du cortex et de connectivité de matière blanche associées à l’ÉI et, d’autre part, de définir les réarrangements de connectivité subséquents à la chirurgie insulaire pour contrôle épileptique. Les deux premières études de cette thèse ont révélé que l’ÉI était associée à un pattern majoritairement ipsilatéral d’atrophie corticale et d’hyperconnectivité impliquant principalement des sous-régions insulaires et des régions connectées à l’insula. De manière intéressante, la topologie de ces changements correspondait, au moins en partie, à celle du réseau épileptique de l’ÉI. Ensuite, la troisième étude visait à décrire, par le biais d’une méta-analyse, l’histoire naturelle postopératoire des patients subissant une chirurgie pour ÉI. Cette analyse a, entre autres, confirmé que cette chirurgie était efficace (66.7% de disparition des crises) et qu’elle était fréquemment accompagnée de complications neurologiques (42.5%) qui, dans la plupart des cas, étaient transitoires (78.7% des complications) et récupéraient entièrement dans les trois mois postopératoires (91.6% des complications transitoires). Finalement, la quatrième étude a révélé que la chirurgie pour ÉI était suivie d’altérations de connectivité diffuses et bilatérales. Notamment, les connexions présentant une augmentation de connectivité concernaient particulièrement des régions localisées soit près de la cavité chirurgicale ou dans l’hémisphère controlatéral à l’intervention. De plus, la majorité de ces renforcements structurels se sont produits dans les six premiers mois suivant la chirurgie, un délai comparable à celui durant lequel la majeure partie de la récupération fonctionnelle postopératoire a été observée dans notre méta-analyse. En somme, nos résultats suggèrent que les altérations morphologiques en lien avec l’ÉI peuvent correspondre à son réseau épileptique sous-jacent. La topologie de ces changements pourrait constituer un biomarqueur structurel diagnostique qui aiderait à la reconnaissance de l’ÉI et, concomitamment, favoriserait possiblement un traitement chirurgical plus adapté et plus efficace. De plus, les augmentations de connectivité postopératoires pourraient correspondre à des réponses neuroplastiques permettant de prendre en charge les fonctions altérées par la chirurgie. Nos constats ont ainsi contribué à la caractérisation des mécanismes étayant la singulière récupération fonctionnelle accompagnant la chirurgie pour ÉI. À plus grande échelle, nos travaux offrent un aperçu du potentiel de l’IRM structurelle à assister au diagnostic de l’épilepsie focale ainsi qu’à participer à la description des changements plastiques subséquents à une résection neurochirurgicale. / Insular epilepsy (IE) is a rare type of focal epilepsy that is difficult to diagnose. In addition to the challenging nature of IE detection, management of patients with this condition is complicated by the tendency of insular seizures to be resistant to anti-seizure medications. For such medically refractory cases, insular surgery constitutes a viable and long-lasting therapeutic option. That said, patients who undergo an insular resection for seizure control frequently develop postoperative neurological deficits; fortunately, most of these impairments recover fully and rapidly. While this favorable postoperative course contributes to improving the outcome of IE surgery, the mechanism underlying the functional recovery remains unknown. Two contemporary structural MRI modalities, namely cortical thickness analysis and tractography, have recently been used to describe characteristic structural alterations of focal epilepsies and to elucidate the postoperative plastic remodeling associated with surgery for extra-insular epilepsy. While these analyses added to our understanding of several localization-related epilepsies, none specifically studied IE. In this thesis, we exploit structural MRI techniques to, first, depict the alterations of cortical thickness and white matter connectivity in IE and, second, define the progressive rearrangements that follow insular surgery for epilepsy. The first two studies of the current thesis showed that IE is associated with a primarily ipsilateral pattern of cortical thinning and hyperconnectivity that mainly involves insular subregions and insula-connected regions. Interestingly, the topology of these changes corresponded, at least in part, to the epileptic network of IE. Furthermore, the third study aimed to describe, via a meta-analysis, the postoperative outcome of patients undergoing surgery for IE. Among other findings, the analysis revealed that insular surgery was effective (66.7% seizure freedom rate) but was associated with a significant risk of neurological complications (42.5%) which, in most cases, were transient (78.7% of all complications) and recovered fully within three months (91.6% of transient complications). Finally, the fourth study showed that surgery for IE was followed by a diffuse pattern of bilateral structural connectivity changes. Notably, connections exhibiting an increase in connectivity were specifically located near the surgical cavity and in the contralateral healthy hemisphere. In addition, the majority of the structural strengthening occurred in the first six months following surgery, a time course that is consistent with the short delay during which most of the postoperative functional recovery was observed in our meta-analysis. Our results suggest that the morphological alterations in IE may reflect its underlying epileptic network. The topology of these changes may constitute a structural biomarker that could help diagnose IE more readily and, concomitantly, potentially enable a more targeted and more effective surgical treatment. Moreover, the postoperative increases in connectivity may be compatible with compensatory neuroplastic responses, a process that arose to recoup the functions of the injured insular cortex. Our findings have therefore contributed to the characterization of the driving process that supports the striking functional recovery seen following surgery for IE. On a larger scale, our work provides insights into the potential of structural MRI to assist in the diagnosis of focal epilepsy and to describe plastic changes following neurosurgical resections.